vs

Side-by-side financial comparison of Blue Bird Corp (BLBD) and iRhythm Holdings, Inc. (IRTC). Click either name above to swap in a different company.

Blue Bird Corp is the larger business by last-quarter revenue ($333.1M vs $208.9M, roughly 1.6× iRhythm Holdings, Inc.). Blue Bird Corp runs the higher net margin — 9.2% vs 2.7%, a 6.6% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 6.1%). Blue Bird Corp produced more free cash flow last quarter ($31.1M vs $14.5M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs -1.9%).

The Blue Bird Corporation is an American bus manufacturer. Headquartered in Fort Valley, Georgia, the company was best known for its production of school buses. The company has also manufactured a wide variety of other bus types, including transit buses, motorhomes, and specialty vehicles such as mobile libraries and mobile police command centers.

iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.

BLBD vs IRTC — Head-to-Head

Bigger by revenue
BLBD
BLBD
1.6× larger
BLBD
$333.1M
$208.9M
IRTC
Growing faster (revenue YoY)
IRTC
IRTC
+21.0% gap
IRTC
27.1%
6.1%
BLBD
Higher net margin
BLBD
BLBD
6.6% more per $
BLBD
9.2%
2.7%
IRTC
More free cash flow
BLBD
BLBD
$16.6M more FCF
BLBD
$31.1M
$14.5M
IRTC
Faster 2-yr revenue CAGR
IRTC
IRTC
Annualised
IRTC
25.8%
-1.9%
BLBD

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BLBD
BLBD
IRTC
IRTC
Revenue
$333.1M
$208.9M
Net Profit
$30.8M
$5.6M
Gross Margin
21.4%
70.9%
Operating Margin
11.3%
1.1%
Net Margin
9.2%
2.7%
Revenue YoY
6.1%
27.1%
Net Profit YoY
7.1%
518.5%
EPS (diluted)
$0.94
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BLBD
BLBD
IRTC
IRTC
Q4 25
$333.1M
$208.9M
Q3 25
$409.4M
$192.9M
Q2 25
$398.0M
$186.7M
Q1 25
$358.9M
$158.7M
Q4 24
$313.9M
$164.3M
Q3 24
$350.2M
$147.5M
Q2 24
$333.4M
$148.0M
Q1 24
$345.9M
$131.9M
Net Profit
BLBD
BLBD
IRTC
IRTC
Q4 25
$30.8M
$5.6M
Q3 25
$36.5M
$-5.2M
Q2 25
$36.5M
$-14.2M
Q1 25
$26.0M
$-30.7M
Q4 24
$28.7M
$-1.3M
Q3 24
$24.7M
$-46.2M
Q2 24
$28.7M
$-20.1M
Q1 24
$26.0M
$-45.7M
Gross Margin
BLBD
BLBD
IRTC
IRTC
Q4 25
21.4%
70.9%
Q3 25
21.1%
71.1%
Q2 25
21.6%
71.2%
Q1 25
19.7%
68.8%
Q4 24
19.2%
70.0%
Q3 24
17.0%
68.8%
Q2 24
20.8%
69.9%
Q1 24
18.4%
66.3%
Operating Margin
BLBD
BLBD
IRTC
IRTC
Q4 25
11.3%
1.1%
Q3 25
12.3%
-4.4%
Q2 25
12.6%
-10.0%
Q1 25
9.4%
-20.5%
Q4 24
10.5%
-2.5%
Q3 24
7.3%
-34.1%
Q2 24
11.9%
-15.5%
Q1 24
10.4%
-28.9%
Net Margin
BLBD
BLBD
IRTC
IRTC
Q4 25
9.2%
2.7%
Q3 25
8.9%
-2.7%
Q2 25
9.2%
-7.6%
Q1 25
7.3%
-19.3%
Q4 24
9.2%
-0.8%
Q3 24
7.0%
-31.3%
Q2 24
8.6%
-13.6%
Q1 24
7.5%
-34.6%
EPS (diluted)
BLBD
BLBD
IRTC
IRTC
Q4 25
$0.94
$0.18
Q3 25
$1.11
$-0.16
Q2 25
$1.12
$-0.44
Q1 25
$0.79
$-0.97
Q4 24
$0.86
$-0.03
Q3 24
$0.71
$-1.48
Q2 24
$0.85
$-0.65
Q1 24
$0.79
$-1.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BLBD
BLBD
IRTC
IRTC
Cash + ST InvestmentsLiquidity on hand
$241.7M
$583.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$271.4M
$152.7M
Total Assets
$642.3M
$1.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BLBD
BLBD
IRTC
IRTC
Q4 25
$241.7M
$583.8M
Q3 25
$229.3M
$565.2M
Q2 25
$173.1M
$545.5M
Q1 25
$130.7M
$520.6M
Q4 24
$136.1M
$535.6M
Q3 24
$127.7M
$522.0M
Q2 24
$88.4M
$561.5M
Q1 24
$93.1M
$569.1M
Stockholders' Equity
BLBD
BLBD
IRTC
IRTC
Q4 25
$271.4M
$152.7M
Q3 25
$255.4M
$121.9M
Q2 25
$221.8M
$103.7M
Q1 25
$190.4M
$86.7M
Q4 24
$179.7M
$90.9M
Q3 24
$159.6M
$71.8M
Q2 24
$137.3M
$99.2M
Q1 24
$105.8M
$90.3M
Total Assets
BLBD
BLBD
IRTC
IRTC
Q4 25
$642.3M
$1.0B
Q3 25
$625.3M
$995.2M
Q2 25
$575.5M
$964.0M
Q1 25
$543.7M
$926.1M
Q4 24
$535.2M
$931.4M
Q3 24
$524.9M
$909.7M
Q2 24
$468.1M
$919.2M
Q1 24
$456.5M
$909.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BLBD
BLBD
IRTC
IRTC
Operating Cash FlowLast quarter
$36.6M
$26.2M
Free Cash FlowOCF − Capex
$31.1M
$14.5M
FCF MarginFCF / Revenue
9.3%
6.9%
Capex IntensityCapex / Revenue
1.6%
5.6%
Cash ConversionOCF / Net Profit
1.19×
4.70×
TTM Free Cash FlowTrailing 4 quarters
$162.6M
$34.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BLBD
BLBD
IRTC
IRTC
Q4 25
$36.6M
$26.2M
Q3 25
$65.1M
$34.9M
Q2 25
$56.9M
$27.7M
Q1 25
$27.8M
$-7.9M
Q4 24
$26.4M
$19.2M
Q3 24
$55.4M
$24.3M
Q2 24
$989.0K
$11.8M
Q1 24
$54.6M
$-52.0M
Free Cash Flow
BLBD
BLBD
IRTC
IRTC
Q4 25
$31.1M
$14.5M
Q3 25
$60.5M
$20.1M
Q2 25
$52.3M
$17.3M
Q1 25
$18.7M
$-17.3M
Q4 24
$21.8M
$12.4M
Q3 24
$50.2M
$15.5M
Q2 24
$-3.5M
$3.4M
Q1 24
$51.8M
$-61.8M
FCF Margin
BLBD
BLBD
IRTC
IRTC
Q4 25
9.3%
6.9%
Q3 25
14.8%
10.4%
Q2 25
13.1%
9.3%
Q1 25
5.2%
-10.9%
Q4 24
7.0%
7.5%
Q3 24
14.3%
10.5%
Q2 24
-1.1%
2.3%
Q1 24
15.0%
-46.8%
Capex Intensity
BLBD
BLBD
IRTC
IRTC
Q4 25
1.6%
5.6%
Q3 25
1.1%
7.7%
Q2 25
1.2%
5.6%
Q1 25
2.5%
5.9%
Q4 24
1.5%
4.2%
Q3 24
1.5%
6.0%
Q2 24
1.3%
5.7%
Q1 24
0.8%
7.4%
Cash Conversion
BLBD
BLBD
IRTC
IRTC
Q4 25
1.19×
4.70×
Q3 25
1.78×
Q2 25
1.56×
Q1 25
1.07×
Q4 24
0.92×
Q3 24
2.24×
Q2 24
0.03×
Q1 24
2.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BLBD
BLBD

Alternative Fuel Buses$151.4M45%
Diesel Buses$144.9M43%
Parts$24.8M7%
Other$12.1M4%

IRTC
IRTC

Commercial Payors$111.7M53%
Centers For Medicare And Medicaid$49.2M24%
Healthcare Institutions$34.3M16%
Non Contracted Third Party Payors$13.7M7%

Related Comparisons